Journal articles on the topic 'CD8+CD38+'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'CD8+CD38+.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Mocroft, A., M. Bofill, M. Lipman, E. Medina, N. Borthwick, A. Timms, L. Batista, et al. "CD8+, CD38+ Lymphocyte Percent." Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 14, no. 2 (February 1997): 158–62. http://dx.doi.org/10.1097/00042560-199702010-00009.
Full textPetrovas, Constantinos, Yvonne M. Mueller, Ioannis D. Dimitriou, Susan R. Altork, Anupam Banerjee, Peter Sklar, Karam C. Mounzer, John D. Altman, and Peter D. Katsikis. "Increased mitochondrial mass characterizes the survival defect of HIV-specific CD8+ T cells." Blood 109, no. 6 (November 9, 2006): 2505–13. http://dx.doi.org/10.1182/blood-2006-05-021626.
Full textAlvarez-Jimenez, Violeta, Jeanet Serafin-Lopez, Sergio Estrada-Parra, Iris Elvira Estrada-García, and Claudia Sandoval-Montes. "Analysis of extrinsic pathway mediators in CD8+CD38+ T cells of healthy donors stimulated with Mycobacterium tuberculosis antigens (99.20)." Journal of Immunology 186, no. 1_Supplement (April 1, 2011): 99.20. http://dx.doi.org/10.4049/jimmunol.186.supp.99.20.
Full textHo, H. N., L. E. Hultin, R. T. Mitsuyasu, J. L. Matud, M. A. Hausner, D. Bockstoce, C. C. Chou, S. O'Rourke, J. M. Taylor, and J. V. Giorgi. "Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens." Journal of Immunology 150, no. 7 (April 1, 1993): 3070–79. http://dx.doi.org/10.4049/jimmunol.150.7.3070.
Full textRíos-Olivares, Eddy, José W. Rodríguez, Luis A. Rodríguez, Madhavan Nair, and Robert Hunter. "Co-expression of apoptosis-related molecules on activated CD8+CD38+ T-cells is associated with HIV-1 disease progression (B213)." Journal of Immunology 178, no. 1_Supplement (April 1, 2007): LB44. http://dx.doi.org/10.4049/jimmunol.178.supp.b213.
Full textCaselli, D., G. Comolli, A. Maccabruni, C. Klersy, and L. Minoli. "CD38/CD8 expression and HAART failure." Lancet 353, no. 9155 (March 1999): 840–41. http://dx.doi.org/10.1016/s0140-6736(05)76500-4.
Full textOstendorf, L., P. Garantziotis, D. L. Wagner, P. Durek, F. Heinrich, P. Enghard, G. R. Burmester, et al. "POS0010 CD38+ MEMORY T CELLS ARE A FUNCTIONALLY DISTINCT SUBSET THAT IS EXPANDED IN SLE AND ASSOCIATED WITH LUPUS NEPHRITIS." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 207.1–207. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3104.
Full textTincati, Camilla, Giusi M. Bellistrì, Giuseppe Ancona, Esther Merlini, Antonella d’Arminio Monforte, and Giulia Marchetti. "Role ofIn VitroStimulation with Lipopolysaccharide on T-Cell Activation in HIV-Infected Antiretroviral-Treated Patients." Clinical and Developmental Immunology 2012 (2012): 1–9. http://dx.doi.org/10.1155/2012/935425.
Full textBai, Francesca, Camilla Tincati, Esther Merlini, Carlotta Pacioni, Elisabetta Sinigaglia, Giovanni Carpani, Antonella d’Arminio Monforte, and Giulia Marchetti. "Reduced Central Memory CD4+ T Cells and Increased T-Cell Activation Characterise Treatment-Naive Patients Newly Diagnosed at Late Stage of HIV Infection." AIDS Research and Treatment 2012 (2012): 1–10. http://dx.doi.org/10.1155/2012/314849.
Full textLawrence Cheung, Chun Chau, Yong Hock Justin Seah, Juntao Fang, Nicole Orpilla, Justina Nadia Li Wen Lee, Han Chong Toh, Su Pin Choo, Kiat Hon Lim, Wai Meng David Tai, and Joe Yeong. "89 The immune marker LAG-3 increases the predictive value of CD38+ immune cells for survival outcome in immunotherapy-treated hepatocellular carcinoma." Journal for ImmunoTherapy of Cancer 9, Suppl 2 (November 2021): A97—A98. http://dx.doi.org/10.1136/jitc-2021-sitc2021.089.
Full textCesano, Alessandra, Sophie Visonneau, Silvia Deaglio, Fabio Malavasi, and Daniela Santoli. "Role of CD38 and Its Ligand in the Regulation of MHC-Nonrestricted Cytotoxic T Cells." Journal of Immunology 160, no. 3 (February 1, 1998): 1106–15. http://dx.doi.org/10.4049/jimmunol.160.3.1106.
Full textЗыблева, С. В., and О. А. Сердюкова. "Peculiarities of the Immune Status of Patients with Atopic Dermatitis." Лабораторная диагностика. Восточная Европа, no. 4 (January 18, 2021): 413–19. http://dx.doi.org/10.34883/pi.2020.9.4.006.
Full textGivens, Tara S., Brian K. DuChateau, Jonathan S. Boomer, Maxwell P. Westerman, Alice Gilman-Sachs, and Kenneth D. Beaman. "Regeneration and Tolerance Factor: a Correlate of Human Immunodeficiency Virus-Associated T-Cell Activation." Clinical Diagnostic Laboratory Immunology 6, no. 6 (November 1, 1999): 872–77. http://dx.doi.org/10.1128/cdli.6.6.872-877.1999.
Full textStoeckler, J. D., H. A. Stoeckler, N. Kouttab, and A. L. Maizel. "1alpha,25-Dihydroxyvitamin D3 modulates CD38 expression on human lymphocytes." Journal of Immunology 157, no. 11 (December 1, 1996): 4908–17. http://dx.doi.org/10.4049/jimmunol.157.11.4908.
Full textMalickaitė, Radvilė, Laimutė Jurgauskienė, Stanislava Simanavičienė, Vytė Valerija Maneikienė, Rita Sudikienė, and Kęstutis Ručinskas. "Imuninė stebėsena širdies transplantacijoje: atmetimo reakcijos poveikis T limfocitų žymenų ekspresijai." Lietuvos chirurgija 8, no. 3 (January 1, 2010): 0. http://dx.doi.org/10.15388/lietchirur.2010.3.2103.
Full textTarbiah, Nesrin I., Nuha A. Alkhattabi, Abdullah J. Alsahafi, Hani S. Aljahdali, Husam M. Joharjy, Maryam H. Al-Zahrani, Aliaa M. Sabban, Rana A. Alghamdi, Maha J. Balgoon, and Reham A. Khalifa. "T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients’ Outcomes." Journal of Clinical Medicine 12, no. 2 (January 16, 2023): 710. http://dx.doi.org/10.3390/jcm12020710.
Full textKumar, Sandeep, Sunil Kumar Singh, Navin Viswakarma, Gautam Sondarva, Rakesh Sathish Nair, Periannan Sethupathi, Matthew Dorman, et al. "Rationalized inhibition of mixed lineage kinase 3 and CD70 enhances life span and antitumor efficacy of CD8+ T cells." Journal for ImmunoTherapy of Cancer 8, no. 2 (August 2020): e000494. http://dx.doi.org/10.1136/jitc-2019-000494.
Full textSteel, Alan, Alison E. Cox, Mohamed H. Shamji, Laurence John, Mark Nelson, Don C. Henderson, Frances M. Gotch, Brian G. Gazzard, and Peter Kelleher. "HIV-1 Viral Replication below 50 Copies/ml in Patients on Antiretroviral Therapy is not associated with CD8+ T-cell Activation." Antiviral Therapy 12, no. 6 (August 2007): 971–76. http://dx.doi.org/10.1177/135965350701200613.
Full textZybleva, S. V., and S. L. Zyblev. "Immunological cluster complexes in kidney transplantation." Medical Immunology (Russia) 24, no. 1 (March 10, 2022): 69–80. http://dx.doi.org/10.15789/1563-0625-icc-2212.
Full textSiewe, Basile, Jack Stapleton, Jeffrey Martinson, Ali Keshavarzian, Nazia Kazmi, Patricia Demarais, Audrey French, and Landay Alan. "Selective Depletion of CD19+CD24hiCD38hiIL-10high Regulatory B cells (Bregs) in HIV-infected Aviremic Individuals (76.2)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 76.2. http://dx.doi.org/10.4049/jimmunol.188.supp.76.2.
Full textЗыблева, С. В., and С. Л. Зыблев. "Cluster Analysis of Leukocyte Subpopulations in Kidney Transplantation." Гематология. Трансфузиология. Восточная Европа, no. 2 (November 8, 2021): 168–75. http://dx.doi.org/10.34883/pi.2021.7.2.005.
Full textCrawford, Timothy, Frederick Hecht, Lishomwa Ndhlovu, and Jason Barbour. "Activated CD8+ T cells exhibit blunted effector functions in early HIV-1 disease (P3035)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 55.18. http://dx.doi.org/10.4049/jimmunol.190.supp.55.18.
Full textPuspitawati, Ira, and Umi S. Intansari. ", DALAM KEADAAN (STATUS) IMUNOLOGIS DAN KLINIS PENGOBATAN ANTIRETROVIRAL PENDERITA HIV/AIDS CD38 LIMFOSIT CD8 + , TAMPANG (PROFIL) CD4 +." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 16, no. 1 (March 17, 2018): 32. http://dx.doi.org/10.24293/ijcpml.v16i1.994.
Full textDrent, Esther, Richard Groen, Willy A. Noort, Jeroen Lammerts van Bueren, Paul W. H. I. Parren, Jurgen H. Kuball, Zsolt Sebestyen, et al. "CD38 Chimeric Antigen Receptor Engineered T Cells As Therapeutic Tools for Multiple Myeloma." Blood 124, no. 21 (December 6, 2014): 4759. http://dx.doi.org/10.1182/blood.v124.21.4759.4759.
Full textOstendorf, L., P. Enghard, P. Durek, F. Heinrich, M. F. Mashreghi, G. R. Burmester, A. Radbruch, F. Hiepe, and T. Alexander. "AB0138 INCREASED CD38 EXPRESSION LEVELS ON IMMUNE CELL SUBSETS IN SYSTEMIC LUPUS ERYTHEMATOSUS." Annals of the Rheumatic Diseases 79, Suppl 1 (June 2020): 1369.2–1370. http://dx.doi.org/10.1136/annrheumdis-2020-eular.6531.
Full textBean, Andrew G. D., Dale I. Godfrey, Walter G. Ferlin, Leopoldo Santos-Argumedo, R. Michael E. Parkhouse, Maureen C. Howard, and Albert Zlotnik. "CD38 expression on mouse T cells: CD38 defines functionally distinct subsets of αβ TCR+CD4−CD8−thymocytes." International Immunology 7, no. 2 (1995): 213–21. http://dx.doi.org/10.1093/intimm/7.2.213.
Full textKassu, Afework, Aster Tsegaye, Beyene Petros, Dawit Wolday, Ermias Hailu, Tesfaye Tilahun, Binyam Hailu, et al. "Distribution of Lymphocyte Subsets in Healthy Human Immunodeficiency Virus-Negative Adult Ethiopians from Two Geographic Locales." Clinical Diagnostic Laboratory Immunology 8, no. 6 (November 1, 2001): 1171–76. http://dx.doi.org/10.1128/cdli.8.6.1171-1176.2001.
Full textBurns, M., L. Ostendorf, A. Grützkau, F. Hiepe, T. Alexander, and H. Mei. "POS0420 DYSREGULATED CD38 EXPRESSION ON PERIPHERAL BLOOD IMMUNE CELL SUBSETS IN SLE." Annals of the Rheumatic Diseases 80, Suppl 1 (May 19, 2021): 439.1–439. http://dx.doi.org/10.1136/annrheumdis-2021-eular.3883.
Full textD’Abramo, Alessandra, Maria Antonella Zingaropoli, Alessandra Oliva, Claudia D’Agostino, Samir Al Moghazi, Giulia De Luca, Marco Iannetta, Claudio Maria Mastroianni, and Vincenzo Vullo. "Immune Activation, Immunosenescence, and Osteoprotegerin as Markers of Endothelial Dysfunction in Subclinical HIV-Associated Atherosclerosis." Mediators of Inflammation 2014 (2014): 1–8. http://dx.doi.org/10.1155/2014/192594.
Full textKitadate, Akihiro, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Daisuke Miura, Masami Takeuchi, and Kosei Matsue. "CD38 Expression Levels on Myeloma Cells and the Frequency of Circulating CD38-Positive Treg Cells Are Associated with the Response to Daratumumab in Multiple Myeloma." Blood 132, Supplement 1 (November 29, 2018): 1883. http://dx.doi.org/10.1182/blood-2018-99-113737.
Full textLischke, Timo, Kira Heesch, Valéa Schumacher, Michael Schneider, Friedrich Haag, Friedrich Koch-Nolte, and Hans-Willi Mittrücker. "CD38 Controls the Innate Immune Response against Listeria monocytogenes." Infection and Immunity 81, no. 11 (August 26, 2013): 4091–99. http://dx.doi.org/10.1128/iai.00340-13.
Full textYagi, Mary Jane, Fo-Nian Chu, Jian Dong Jiang, Joyce Wallace, Patricia Mason, Yuan Liu, Joyce Carafa, and J. George Bekesi. "Increases in soluble CD8 antigen in plasma, and CD8+ and CD8+CD38+ cells in human immunodeficiency virus type-1 infection." Clinical Immunology and Immunopathology 63, no. 2 (May 1992): 126–34. http://dx.doi.org/10.1016/0090-1229(92)90004-8.
Full textChandele, Anmol, Jaturong Sewatanon, Sivaram Gunisetty, Mohit Singla, Nattawat Onlamoon, Rama S. Akondy, Haydn Thomas Kissick, et al. "Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India." Journal of Virology 90, no. 24 (October 5, 2016): 11259–78. http://dx.doi.org/10.1128/jvi.01424-16.
Full textPerfetto, Stephen P., John D. Malone, Clifton Hawkes, Gilbert McCrary, Bob August, Susan Zhou, Robin Garner, Matthew J. Dolan, and Arthur E. Brown. "CD38 expression on cryopreserved CD8+ T cells predicts HIV disease progression." Cytometry 33, no. 2 (October 1, 1998): 133–37. http://dx.doi.org/10.1002/(sici)1097-0320(19981001)33:2<133::aid-cyto7>3.0.co;2-k.
Full textHuang, Nick, Brandon Wyman, Emma Cravo, Thomas Winans, Gourav Choudhary, Zachary Oaks, Manuel Duarte, et al. "Rab4A inactivation in T cells blocks mTOR activation, pro-inflammatory lineage development, and disease pathogenesis in lupus-prone mice." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 115.6. http://dx.doi.org/10.4049/jimmunol.202.supp.115.6.
Full textKovacs, Andrea A. Z., Naoko Kono, Chia-Hao Wang, Daidong Wang, Toni Frederick, Eva Operskalski, Phyllis C. Tien, et al. "Association of HLA Genotype With T-Cell Activation in Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus–Coinfected Women." Journal of Infectious Diseases 221, no. 7 (November 10, 2019): 1156–66. http://dx.doi.org/10.1093/infdis/jiz589.
Full textKandilarova, Snezhina M., Atanaska I. Georgieva, Anastasiya P. Mihaylova, Marta P. Baleva, Valentina K. Atanasova, Diana V. Petrova, Georgi T. Popov, and Elissaveta J. Naumova. "Immune Cell Subsets Evaluation as a Predictive Tool for Hepatitis B Infection Outcome and Treatment Responsiveness." Folia Medica 59, no. 1 (March 1, 2017): 53–62. http://dx.doi.org/10.1515/folmed-2017-0008.
Full textGiraldo, Nicolas, Natalia Bolaños, Adriana Cuellar, Nubia Roa, Zulma Cucunubá, Victor Velasco, Fernando Rosas, Concepción Puerta, and John González. "Proliferative dysfunction in chronically activated T lymphocytes from chagasic patients (70.1)." Journal of Immunology 188, no. 1_Supplement (May 1, 2012): 70.1. http://dx.doi.org/10.4049/jimmunol.188.supp.70.1.
Full textNakajima, Shihoko, Asako Chiba, Ayako Makiyama, Eri Hayashi, Goh Murayama, Ken Yamaji, Shigeto Kobayashi, Naoto Tamura, Yoshinari Takasaki, and Sachiko Miyake. "Association of mucosal-associated invariant T cells with different disease phases of polymyalgia rheumatica." Rheumatology 59, no. 10 (March 3, 2020): 2939–46. http://dx.doi.org/10.1093/rheumatology/keaa054.
Full textBurns, Marie, Lennard Ostendorf, Robert Biesen, Andreas Grützkau, Falk Hiepe, Henrik E. Mei, and Tobias Alexander. "Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE." International Journal of Molecular Sciences 22, no. 5 (February 28, 2021): 2424. http://dx.doi.org/10.3390/ijms22052424.
Full textManna, Alak, Sonikpreet Aulakh, Taimur Sher, Sikander Ailawadhi, Asher Chanan-Khan, and Aneel Paulus. "CD38hi B-regulatory (B-reg) cells maintain pathological immune tolerance in chronic lymphocytic leukemia (CLL)/B cell diseases: Potential therapeutic considerations." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 71.13. http://dx.doi.org/10.4049/jimmunol.202.supp.71.13.
Full textDistler, Eva, Anna Jürchott, Abdo Konur, Astrid Schneider, Eva M. Wagner, Christoph Huber, Ralf G. Meyer, and Wolfgang Herr. "The CD38-Positive and CD38-Negative Subsets of CD34(high)-Positive Primary Acute Myeloid Leukemia Blasts Differ Considerably in the Expression of Immune Recognition Molecules." Blood 112, no. 11 (November 16, 2008): 2936. http://dx.doi.org/10.1182/blood.v112.11.2936.2936.
Full textde Carvalho, Paulo Germano, Raphael de Oliveira Rodrigues, Silvia Fernandes Ribeiro da Silva, Ilana Farias Ribeiro, Herene Barros de Miranda Lucena, Lilian Roberta Costa Martins, Silvia Helena Rabenhorst, Érico Antônio Gomes de Arruda, and Aparecida Tiemi Nagao-Dias. "CD38+CD8+ and CD38+CD4+ T Cells and IFN Gamma (+874) Polymorphism Are Associated with a Poor Virological Outcome." Immunological Investigations 45, no. 4 (April 21, 2016): 312–27. http://dx.doi.org/10.3109/08820139.2016.1157603.
Full textEller, Michael A., Nilu Goonetilleke, Boonrat Tassaneetrithep, Leigh Anne Eller, Margaret C. Costanzo, Susan Johnson, Michael R. Betts, et al. "Expansion of Inefficient HIV-Specific CD8 T Cells during Acute Infection." Journal of Virology 90, no. 8 (February 3, 2016): 4005–16. http://dx.doi.org/10.1128/jvi.02785-15.
Full textCollins, Sabrina, Adarsh Joshi, Lei Shen, Subhasree Das, Kaveri Suryanarayan, Dean Bottino, Cheryl Li, et al. "357 TAK-573, an anti-CD38–attenuated interferon alpha (IFNα) fusion protein (Attenukine™), has demonstrated IFNα receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A382. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0357.
Full textDemosthenes, John Paul, Gnanadurai John Fletcher, Uday George Zachariah, George Mannil Varghese, Susanne Alexander Pulimood, Priya Abraham, and Rajesh Kannangai. "Chronic Immune Activation Among Treatment Naïve HIV/ HBV Coinfected Individuals From Southern India." Current HIV Research 19, no. 4 (August 30, 2021): 332–41. http://dx.doi.org/10.2174/1570162x19666210506160642.
Full textBeran, Ondrej, Petr Kodym, Marek Maly, Alzbeta Davidova, Gabriela Reinvartova, David Jilich, Michal Holub, and Hanus Rozsypal. "The Effect of LatentToxoplasma gondiiInfection on the Immune Response in HIV-Infected Patients." BioMed Research International 2015 (2015): 1–7. http://dx.doi.org/10.1155/2015/271842.
Full textSun, Changbo, Koji Nagaoka, Yukari Kobayashi, Hidewaki Nakagawa, Kazuhiro Kakimi, and Jun Nakajima. "Neoantigen Dendritic Cell Vaccination Combined with Anti-CD38 and CpG Elicits Anti-Tumor Immunity against the Immune Checkpoint Therapy-Resistant Murine Lung Cancer Cell Line LLC1." Cancers 13, no. 21 (November 2, 2021): 5508. http://dx.doi.org/10.3390/cancers13215508.
Full textOmede, P., M. Boccadoro, G. Gallone, R. Frieri, S. Battaglio, V. Redoglia, and A. Pileri. "Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival." Blood 76, no. 7 (October 1, 1990): 1375–79. http://dx.doi.org/10.1182/blood.v76.7.1375.1375.
Full textOmede, P., M. Boccadoro, G. Gallone, R. Frieri, S. Battaglio, V. Redoglia, and A. Pileri. "Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival." Blood 76, no. 7 (October 1, 1990): 1375–79. http://dx.doi.org/10.1182/blood.v76.7.1375.bloodjournal7671375.
Full text